15.Gallagher CG: Exercise and chronic obstructive pulmonary disease. Med Clin North Am 1990; 74:619-641.
16.Gladden LB: Current "anaerobic threshold" controversies. Physiologist 1984; 27:312-318.
17.Gladden LB: Lactate metabolism: a new paradigm for the third millennium. J Physiol 2004; 558:5-30.
18.Gold WM: Pulmonary function testing. In: Murray JF, Nadel JA, ed. Textbook of Respiratory Medicine, Vol 1. 3rd ed. Philadelphia: WB Saunders; 2000:855.
19.Gosker HR, Lencer NH, Franssen FM, et al: Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003; 123:1416-1424.
20.Hansen JE, Sue DY, Wasserman K: Predicted values for clinical exercise testing. Am Rev Respir Dis 1984; 129:S49-S55.
21.Hsia CC: Cardiopulmonary limitations to exercise in restrictive lung disease. Med Sci Sports Exerc 1999; 31:S28-S32.
22.Hyatt RE: Expiratory flow limitation. J Appl Physiol 1983; 55:1-7.
23.In: Weisman IM, Zeballos RJ, ed. Progress in Respiratory Research. Vol 32: Clinical Exercise Testing, Basel: Karger; 1999.
24.Johnson BD, Weisman IM, Zeballos RJ, et al: Emerging concepts in the evaluation of ventilatory limitation during exercise: The exercise tidal flow-volume loop. Chest 1999; 116:488-503.
25.Jones NL, Campbell EJM: Clinical Exercise Testing, 2nd ed. Philadelphia, WB Saunders, 1982.
26.Jones NL, Makrides L, Hitchcock C, et al: Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131:700-708.
27.Killian KJ, Summers E, Jones NL, et al: Dyspnea and leg effort during incremental cycle ergometry. Am Rev Respir Dis 1992; 145:1339-1345.
28.Leaver DG, Pride NB: Flow-volume curves and expiratory pressures during exercise in patients with chronic airways obstruction. Scand J Respir Dis Suppl 1971; 77:23-27.
29.Leblanc P, Bowie DM, Summers E, et al: Breathlessness and exercise in patients with cardiorespiratory disease. Am Rev Respir Dis 1986; 133:21-25.
30.Levison H, Cherniack RM: Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol 1968; 25:21-27.
31.MacRae HSH, Dennis SC, Bosch AN, et al: Effects of training on lactate production and removal during progressive exercise in humans. J Appl Physiol 1992; 72:1649-1656.
32.Mador MJ, Kufel TJ, Pineda LA, et al: Diaphragmatic fatigue and high-intensity exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:118-123.
33.Medoff BD, Oelberg DA, Kanarek DJ, et al: Breathing reserve at the lactate threshold to differentiate a pulmonary mechanical from cardiovascular limit to exercise. Chest 1998; 113:913-918.
34.Miyamoto S, Nagaya N, Satoh T, et al: Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161:487-492.
35.Mohsenifar Z, Tashkin DP, Levy SE, et al: Lack of sensitivity of measurements of Vd/Vt at rest and during exercise in detection of hemodynamically significant pulmonary vascular abnormalities in collagen vascular disease. Am Rev Respir Dis 1981; 123:508-512.
36.Mohsenifar Z, Tashkin DP, Wolfe JD, et al: Abnormal responses of wasted ventilation fraction (VD/VT) during exercise in patients with pulmonary vascular abnormalities. Respiration 1983; 44:44-49.
37.Montes de Oca M, Celli BR: Respiratory muscle recruitment and exercise performance in eucapnic and hypercapnic severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:880-885.
38.Montes de Oca M, Rassulo J, Celli BR: Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154:1284-1289.
39.Morrison DA, Adcock K, Collins CM, et al: Right ventricular dysfunction and the exercise limitation of chronic obstructive pulmonary disease. J Am Coll Cardiol 1987; 9:1219-1229.
40.Morrison DA, Stovall JR: Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. Chest 1992; 102:542-550.
41.Nordenfelt I, Svensson G: The transfer factor (diffusing capacity) as a predictor of hypoxaemia during exercise in restrictive and chronic obstructive pulmonary disease. Clin Physiol 1987; 7:423-430.
42.O'Donnell DE, Bain DJ, Webb KA: Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med 1997; 155:530-535.
43.O'Donnell DE, Bertley JC, Chau LK, et al: Qualitative aspects of exertional breathlessness in chronic airflow limitation: Pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155:109-115.
44.O'Donnell DE, Revill SM, Webb KA: Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:770-777.
45.O'Donnell DE, Sanii R, Anthonisen NR, et al: Effect of dynamic airway compression on breathing pattern and respiratory sensation in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1987; 135:912-918.
46.O'Donnell DE, Webb KA: Breathlessness in patients with severe chronic airflow limitation: Physiologic correlations. Chest 1992; 102:824-831.
47.O'Donnell DE, Webb KA: Exertional breathlessness in patients with chronic airflow limitation: The role of lung hyperinflation. Am Rev Respir Dis 1993; 148:1351-1357.
48.O'Donnell DE: Breathlessness in patients with chronic airflow limitation: Mechanisms and management. Chest 1994; 106:904-912.
49.Oelberg DA, Kacmarek RM, Pappagianopoulos PP, et al: Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:1876-1882.
50.Oelberg DA, Systrom DM, Markowitz DH, et al: Exercise performance in cystic fibrosis before and after bilateral lung transplantation. J Heart Lung Transplant 1998; 17:1104-1112.
51.Polkey MI, Kyroussis D, Mills GH, et al: Inspiratory pressure support reduces slowing of inspiratory muscle relaxation rate during exhaustive treadmill walking in severe COPD. Am J Respir Crit Care Med 1996; 154:1146-1150.
52.Potter WA, Olafsson S, Hyatt RE: Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J Clin Invest 1971; 50:910-919.
53.Pride NB, Macklem PT: Lung mechanics in disease. In: Macklem PT, Mead J, ed. Handbook of Physiology. Section 3: The Respiratory System. Vol II: Mechanics of Breathing, Baltimore: Williams & Wilkins; 1986:659-692.
54.Raeside DA, Smith A, Brown A, et al: Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension. Eur Respir J 2000; 16:282-287.
55.Reeves JT, Moon RE, Grover RF, et al: Increased wedge pressure facilitates decreased lung vascular resistance during upright exercise. Chest 1988; 93:97S-99S.
56.Rhodes J, Barst RJ, Garofano RP, et al: Hemodynamic correlates of exercise function in patients with primary pulmonary hypertension. J Am Coll Cardiol 1991; 18:1738-1744.
57.Richardson RS, Noyszewski EA, Leigh JS, et al: Lactate efflux from exercising human skeletal muscle: Role of intracellular PO2. J Appl Physiol 1998; 85:627-634.
58.Richardson RS, Sheldon J, Poole DC, et al: Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:881-885.
59.Risk C, Epler GR, Gaensler EA: Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease. Chest 1984; 85:69-74.
60.Sexton WL, Poole DC: Effects of emphysema on diaphragm blood flow during exercise. J Appl Physiol 1998; 84:971-979.
61.Simon M, LeBlanc P, Jobin J, et al: Limitation of lower limb VO2 during cycling exercise in COPD patients. J Appl Physiol 2001; 90:1013-1019.
